tiprankstipranks
Advertisement
Advertisement
Roche and Zealand Advance Combo Obesity Drug Trial, Signaling New Momentum for ZLDPF
PremiumCompany AnnouncementsRoche and Zealand Advance Combo Obesity Drug Trial, Signaling New Momentum for ZLDPF
2M ago
Zealand Pharma announces Boehringer’s phase III results of survodutide
Premium
The Fly
Zealand Pharma announces Boehringer’s phase III results of survodutide
2M ago
Zealand Pharma presents additional data from ZUPREME-1 trial
Premium
The Fly
Zealand Pharma presents additional data from ZUPREME-1 trial
2M ago
Zealand Pharma Advances Obesity Pipeline With Completed Petrelintide Dose Study
PremiumCompany AnnouncementsZealand Pharma Advances Obesity Pipeline With Completed Petrelintide Dose Study
4M ago
Zealand Pharma establishes U.S. research hub in Cambridge, Massachusetts
Premium
The Fly
Zealand Pharma establishes U.S. research hub in Cambridge, Massachusetts
4M ago
Zealand Pharma price target lowered to DKK 275 from DKK 450 at Deutsche Bank
Premium
The Fly
Zealand Pharma price target lowered to DKK 275 from DKK 450 at Deutsche Bank
5M ago
Zealand Pharma downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyZealand Pharma downgraded to Neutral from Overweight at Cantor Fitzgerald
5M ago
Zealand Pharma downgraded to Hold from Buy at SEB Equities
Premium
The Fly
Zealand Pharma downgraded to Hold from Buy at SEB Equities
5M ago
Zealand Pharma downgraded to Hold from Buy at Nordea
Premium
The Fly
Zealand Pharma downgraded to Hold from Buy at Nordea
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100